These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 32133348)

  • 1. LINC00346 Acts as a Competing Endogenous RNA Regulating Development of Hepatocellular Carcinoma via Modulating CDK1/CCNB1 Axis.
    Jin J; Xu H; Li W; Xu X; Liu H; Wei F
    Front Bioeng Biotechnol; 2020; 8():54. PubMed ID: 32133348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-Induced lncRNA-NEAT1 Sustains the Growth of Hepatocellular Carcinoma via Regulation of miR-199a-3p/UCK2.
    Zhang Q; Cheng Q; Xia M; Huang X; He X; Liao J
    Front Oncol; 2020; 10():998. PubMed ID: 32670881
    [No Abstract]   [Full Text] [Related]  

  • 3. LINC00346 Sponges miR-30c-2-3p to Promote the Development of Lung Adenocarcinoma by Targeting MYBL2 and Regulating CELL CYCLE Signaling Pathway.
    Xu Q; Xu Z; Zhu K; Lin J; Ye B
    Front Oncol; 2021; 11():687208. PubMed ID: 34631522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiRNA199a-3p suppresses tumor growth, migration, invasion and angiogenesis in hepatocellular carcinoma by targeting VEGFA, VEGFR1, VEGFR2, HGF and MMP2.
    Ghosh A; Dasgupta D; Ghosh A; Roychoudhury S; Kumar D; Gorain M; Butti R; Datta S; Agarwal S; Gupta S; Krishna Dhali G; Chowdhury A; Schmittgen TD; Kundu GC; Banerjee S
    Cell Death Dis; 2017 Mar; 8(3):e2706. PubMed ID: 28358369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-199a-3p inhibits tumorigenesis of hepatocellular carcinoma cells by targeting ZHX1/PUMA signal.
    Guan J; Liu Z; Xiao M; Hao F; Wang C; Chen Y; Lu Y; Liang J
    Am J Transl Res; 2017; 9(5):2457-2465. PubMed ID: 28559996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration and validation of downregulated microRNA-199a-3p, downstream messenger RNA targets and transcriptional regulation in osteosarcoma.
    Huang WT; Liu AG; Cai KT; He RQ; Li Z; Wei QJ; Chen MY; Huang JY; Yan WY; Zhou H; Chen G; Ma J
    Am J Transl Res; 2019; 11(12):7538-7554. PubMed ID: 31934299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C1QTNF1-AS1 regulates the occurrence and development of hepatocellular carcinoma by regulating miR-221-3p/SOCS3.
    Li H; Zhang B; Ding M; Lu S; Zhou H; Sun D; Wu G; Gan X
    Hepatol Int; 2019 May; 13(3):277-292. PubMed ID: 31069760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-29c-3p Suppresses the Migration, Invasion and Cell Cycle in Esophageal Carcinoma via CCNA2/p53 Axis.
    Wang H; Fu L; Wei D; Wang B; Zhang C; Zhu T; Ma Z; Li Z; Wu Y; Yu G
    Front Bioeng Biotechnol; 2020; 8():75. PubMed ID: 32154226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huanglian decoction suppresses the growth of hepatocellular carcinoma cells by reducing
    Li M; Shang H; Wang T; Yang SQ; Li L
    World J Gastroenterol; 2021 Mar; 27(10):939-958. PubMed ID: 33776365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-invasion and anti-migration effects of miR-199a-3p in hepatocellular carcinoma are due in part to targeting CD151.
    Kim JH; Badawi M; Park JK; Jiang J; Mo X; Roberts LR; Schmittgen TD
    Int J Oncol; 2016 Nov; 49(5):2037-2045. PubMed ID: 27599545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aberrant expression of LINC00346 regulates cell migration and proliferation via competitively binding to miRNA-148a-3p/Dnmt1 in Hirschsprung's disease.
    Li L; Li X; Wang X; Liu W; Wu R
    Pediatr Surg Int; 2022 Sep; 38(9):1273-1281. PubMed ID: 35836014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA LINC00346 promotes pancreatic cancer growth and gemcitabine resistance by sponging miR-188-3p to derepress BRD4 expression.
    Shi W; Zhang C; Ning Z; Hua Y; Li Y; Chen L; Liu L; Chen Z; Meng Z
    J Exp Clin Cancer Res; 2019 Feb; 38(1):60. PubMed ID: 30728036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA OSER1-AS1 acts as a ceRNA to promote tumorigenesis in hepatocellular carcinoma by regulating miR-372-3p/Rab23 axis.
    Fan J; Zhang J; Huang S; Li P
    Biochem Biophys Res Commun; 2020 Jan; 521(1):196-203. PubMed ID: 31635804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mouse-specific up-regulation of
    Kim BK; Kim I; Lee AR; Yoo HI; Yoon SK
    FEBS Open Bio; 2016 Nov; 6(11):1131-1140. PubMed ID: 27833853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic study on the treatment of hepatitis B-related hepatocellular carcinoma with drugs based on bioinformatics and key target reverse network pharmacology and experimental verification.
    Li S; Hao L; Hu X; Li L
    Infect Agent Cancer; 2023 Jul; 18(1):41. PubMed ID: 37393234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA PTPRG-AS1 Promotes the Metastasis of Hepatocellular Carcinoma by Enhancing YWHAG.
    Chen G; Zhang Z; Li Y; Wang L; Liu Y
    J Oncol; 2021; 2021():3624306. PubMed ID: 34876904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators.
    Wang P; Chen S; Fang H; Wu X; Chen D; Peng L; Gao Z; Xie C
    Oncotarget; 2016 Jan; 7(1):929-45. PubMed ID: 26498144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA CASC2 inhibited the viability and induced the apoptosis of hepatocellular carcinoma cells through regulating miR-24-3p.
    Fan JC; Zeng F; Le YG; Xin L
    J Cell Biochem; 2018 Aug; 119(8):6391-6397. PubMed ID: 29091305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mir-452-3p: A Potential Tumor Promoter That Targets the CPEB3/EGFR Axis in Human Hepatocellular Carcinoma.
    Tang H; Zhang J; Yu Z; Ye L; Li K; Ding F; Feng X; Meng W
    Technol Cancer Res Treat; 2017 Dec; 16(6):1136-1149. PubMed ID: 29332449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.